Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia
Titel:
Phase I and pharmacodynamic study of Triapine®, a novel ribonucleotide reductase inhibitor, in patients with advanced leukemia
Auteur:
Giles, Francis J. Fracasso, Paula M. Kantarjian, Hagop M. Cortes, Jorge E. Brown, Randy A. Verstovsek, Srdan Alvarado, Yesid Thomas, Deborah A. Faderl, Stefan Garcia-Manero, Guillermo Wright, Lisa P. Samson, Tom Cahill, Ann Lambert, Paula Plunkett, William Sznol, Mario DiPersio, John F. Gandhi, Varsha